NCT05652361 Machine Learning-based Surgical Guidance System for Robot-assisted Rectal Surgery
| NCT ID | NCT05652361 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Technische Universität Dresden |
| Condition | Rectum Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 12 participants |
| Start Date | 2026-02-25 |
| Primary Completion | 2027-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 12 participants in total. It began in 2026-02-25 with a primary completion date of 2027-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of the study is to evaluate the technical feasibility and applicability of a surgical assistance system based on image recognition algorithms in a first-in-human pilot study. In addition, this study will provide preliminary data on the oncological outcome of the assistance system.
Eligibility Criteria
Inclusion Criteria: * Patients with rectal cancer scheduled for robot-assisted rectal resection * Intact preoperative urogenital/rectal function * Full capability of consent Exclusion Criteria: * Previous/Second malignant disease \<5 years before diagnosis of rectal cancer * Previous abdominal surgery, except for laparoscopic appendectomy, laparoscopic cholecystectomy or Cesarean section * Pregnant or breastfeeding women * Addiction or illness that prevent the person concerned from assessing the nature and scope of the clinical trial and its possible consequences * indication that the participant is unlikely to comply with the trial protocoll (e.g. lack of compliance) * official or court order for involuntary hospitalization
Contact & Investigator
Marius Distler, Prof. Dr.
PRINCIPAL INVESTIGATOR
University Hospital Carl Gustav Carus Dresden
Frequently Asked Questions
Who can join the NCT05652361 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Rectum Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05652361 currently recruiting?
Yes, NCT05652361 is actively recruiting participants. Contact the research team at marius.distler@ukdd.de for enrollment information.
Where is the NCT05652361 trial being conducted?
This trial is being conducted at Dresden, Germany.
Who is sponsoring the NCT05652361 clinical trial?
NCT05652361 is sponsored by Technische Universität Dresden. The principal investigator is Marius Distler, Prof. Dr. at University Hospital Carl Gustav Carus Dresden. The trial plans to enroll 12 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.